Christopher A. Haskell
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Atherosclerosis and Cardiovascular Diseases
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Response and Inflammation
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
Papers in
-
- Cell Adhesion Molecules Research 4
- Immunology 10
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Atherosclerosis and Cardiovascular Diseases 3
- Phagocytosis and Immune Regulation 2
- Co-authors
- Israel CharoPhilippe LesnikMasataka BabaShin TakagiMayumi KakizakiThomas J. SchallToshio ImaiHisayuki Nomiyama
- Journals
- Journal of Clinical Investigation (4 papers)Journal of Biological Chemistry (3 papers)Current Vascular Pharmacology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Biochemistry (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Christopher A. Haskell
15 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 1.6k
- Immunology and Allergy 422
- Oncology 1.6k
- Neurology 317
- Rheumatology 172
Countries citing papers authored by Christopher A. Haskell
This map shows the geographic impact of Christopher A. Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Haskell more than expected).
Fields of papers citing papers by Christopher A. Haskell
This network shows the impact of papers produced by Christopher A. Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Haskell. The network helps show where Christopher A. Haskell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher A. Haskell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2010 | 46 | |
| 3 | 2009 | 154 | |
| 4 | 2008 | 29 | |
| 5 | 2005 | 35 | |
| 6 | 2005 | 27 | |
| 7 | 2004 | 7 | |
| 8 | 2003 | 387 | |
| 9 | 2003 | 36 | |
| 10 | Chemokines in transplant rejection. | 2002 | 8 |
| 11 | 2001 | 137 | |
| 12 | 2001 | 180 | |
| 13 | 2001 | 12 | |
| 14 | 2000 | 106 | |
| 15 | 1999 | 199 | |
| 16 | Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion Hit paper breakdown → | 1997 | 1185 |
About Christopher A. Haskell
Christopher A. Haskell is a scholar working on Immunology and Allergy, Immunology, Oncology, Transplantation and Physical and Theoretical Chemistry, having authored 16 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (10 papers), Immunotherapy and Immune Responses (4 papers), Cell Adhesion Molecules Research (4 papers), T-cell and B-cell Immunology (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Glycosylation and Glycoproteins Research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Immunology (1.6k citations), Immunology and Allergy (422 citations), Oncology (1.6k citations), Neurology (317 citations) and Rheumatology (172 citations). Christopher A. Haskell has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Israel Charo, Philippe Lesnik, Masataka Baba, Shin Takagi, Mayumi Kakizaki, Thomas J. Schall, Toshio Imai, Hisayuki Nomiyama, Kunio Hieshima and Morio Nagira. Their work appears in journals such as Journal of Clinical Investigation, Journal of Biological Chemistry, Current Vascular Pharmacology, Bioorganic & Medicinal Chemistry Letters and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.